Novo Nordisk A/S ADR(NVO)
130.61
Change: 0 (0)
As of Tue 12/20/2022 02:54 PM% Of Value
Growth
Value Per Share
:
:
:
94.77
-8.18
102.8100 (as of 19/12/2022)
Fundamentals Data
| Open | 130.75 | Dividend | 2535 |
| Close Price | 130.61 | DivYield | 3.05 % |
| High | 131.0565 | Growth | -221.5 M |
| Low | 129.79 | Growth% | -8.18 |
| P/e | 20.385 | Volume | 1.8 M |
| P/b | 2.14 | Market Capital | 326.5 B |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 115.34 (as of 20/12/2022) | 50 Days Moving Average Percentage | 13.720825852783 (as of 20/12/2022 |
| Industry: Major Pharmaceuticals |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 | Year2 | Year3 | Year4 | Current Year / 2018 |
| Revenue | 0.0 | 107.9 B | 111.7 B | 111.6 B | 111.8 B |
| Cap Spending | 0.0 | -5.2 B | -7.0 B | -7.6 B | -9.6 B |
| Operating Expenses | 0.0 | 49.2 B | 47.6 B | 45.0 B | 46.9 B |
| Operating Cash Flow | 0.0 | 42.4 B | 46.9 B | 48.9 B | 47.2 B |
| Free Cash Flow | 0.0 | 33.0 B | 41.2 B | 33.5 B | 34.9 B |
| Free Cash Flow Per Share | 12.722 | 16.178 | 13.42 | 14.283 | |
| Total liabilities | 0.0 | 1.0 B | 229.0 M | 1.6 B | 515.0 M |
| Total cash | 0.0 | 16.9 B | 18.6 B | 18.8 B | 15.6 B |
| ROE% | 0.822 | 0.802 | 0.76 | ||
| Outstanding Shares | 0.0 | 2.6 B | 2.5 B | 2.5 B | 2.4 B |
| P/E | 23.696 | 16.2 | 19.314 | 20.385 | |
| P/S | 7.654 | 5.496 | 6.593 | 7.041 | |
| Revenue USD | 0.0 | 16.2 B | 15.9 B | 18.3 B | 16.8 B |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|